Yves Dumoulin

Title: Yves Dumoulin: Innovator in Pharmaceutical Technology

Introduction

Yves Dumoulin is a notable inventor based in Canada, recognized for his contributions to pharmaceutical technology. He holds a total of 4 patents, showcasing his innovative approach to improving medical treatments.

Latest Patents

One of his latest inventions is a mesalamine rectal suppository designed to enhance user comfort. This invention includes various embodiments, such as a suppository comprising mesalamine and one or more pharmaceutically acceptable excipients, with a drug load ranging from 35% to 50%. Another embodiment features mesalamine with a tap density between 600 to 800 g/L and a hard fat with a melting point of 32 to 35.5°C. Additionally, the suppository includes mesalamine particles with a surface area ranging from 0.1 m/g to 2.8 m/g. The invention also outlines methods for preparing these suppositories and determining their dissolution parameters.

Career Highlights

Yves Dumoulin has worked with several prominent companies in the pharmaceutical industry, including Aptalis Pharma Canada Inc. and Axcan Pharma Inc. His experience in these organizations has contributed significantly to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Carl Gauthier and David Powell, who have collaborated with him on various projects throughout his career.

Conclusion

Yves Dumoulin's work in the field of pharmaceutical technology exemplifies his commitment to innovation and improving patient care. His patents reflect a deep understanding of the complexities involved in drug formulation and delivery.